<p>Top panel shows Kaplan-Meyer plot summarizing time to a viral load of more than 5,000 copies/ml in both arms. Second panel shows viral load (mean ± standard error) per arm during 27 wk of TI (median time of phase II). Bottom table shows number of patients at time points shown for viral load in the second panel; the decrease in viral load over time is due to the reinitiation of therapy in patients with higher viral loads.</p
Objective: To determine markers that are associated with the durability of virologic response to the...
Objectives and design: The dynamics of viral decline following the initiation of antiretroviral trea...
Most HIV-infected patients who initiate combination antiretroviral therapy experience a viral load d...
Introduction: The goal of antiretroviral treatment (ART) in HIV-1 infection is the permanent suppres...
<p>Plasma viral load (pVl) is shown as Log10 HIV-1 RNA copies/ml. CD4+ T-cell count is shown as cell...
To compare early decrease of HIV plasma viral load (pVL) after two standard combinations of highly a...
<p>HIV-RNA load (A) and CD4∶CD8 ratios (B) in patients with high HIV-RNA as compared to the other pa...
<p><b>A</b>) Plasma HIV-1 RNA decreased for 5 patients, increased for 3 patients, and was below the ...
CONTEXT: It is unclear whether delay in initiation of antiretroviral therapy (ART) may lead to a poo...
<div><p>(A) Survival curves of time to virologic failure during the first three supervised treatment...
<p>This scatter plot shows each HIV viral load measurement (copies/ml on y-axis) vs. time (x-axis) w...
<p>Plasma viral load in RNA copies/ml is plotted on a log<sub>10</sub> scale along the left vertical...
<p>The upper panels show HIV-1 RNA counts for patients who started therapy in the mono/dual era (A) ...
<p>Panel A. presents weeks to re-emergent virus and panel B presents temporal levels of viral RNA th...
HIV-1 RNA plasma concentration at viral set-point is associated not only with disease outcome but al...
Objective: To determine markers that are associated with the durability of virologic response to the...
Objectives and design: The dynamics of viral decline following the initiation of antiretroviral trea...
Most HIV-infected patients who initiate combination antiretroviral therapy experience a viral load d...
Introduction: The goal of antiretroviral treatment (ART) in HIV-1 infection is the permanent suppres...
<p>Plasma viral load (pVl) is shown as Log10 HIV-1 RNA copies/ml. CD4+ T-cell count is shown as cell...
To compare early decrease of HIV plasma viral load (pVL) after two standard combinations of highly a...
<p>HIV-RNA load (A) and CD4∶CD8 ratios (B) in patients with high HIV-RNA as compared to the other pa...
<p><b>A</b>) Plasma HIV-1 RNA decreased for 5 patients, increased for 3 patients, and was below the ...
CONTEXT: It is unclear whether delay in initiation of antiretroviral therapy (ART) may lead to a poo...
<div><p>(A) Survival curves of time to virologic failure during the first three supervised treatment...
<p>This scatter plot shows each HIV viral load measurement (copies/ml on y-axis) vs. time (x-axis) w...
<p>Plasma viral load in RNA copies/ml is plotted on a log<sub>10</sub> scale along the left vertical...
<p>The upper panels show HIV-1 RNA counts for patients who started therapy in the mono/dual era (A) ...
<p>Panel A. presents weeks to re-emergent virus and panel B presents temporal levels of viral RNA th...
HIV-1 RNA plasma concentration at viral set-point is associated not only with disease outcome but al...
Objective: To determine markers that are associated with the durability of virologic response to the...
Objectives and design: The dynamics of viral decline following the initiation of antiretroviral trea...
Most HIV-infected patients who initiate combination antiretroviral therapy experience a viral load d...